- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 473/30 - Oxygen atom attached in position 6, e.g. hypoxanthine
Patent holdings for IPC class C07D 473/30
Total number of patents in this class: 167
10-year publication summary
|
16
|
12
|
15
|
18
|
9
|
5
|
13
|
6
|
7
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BeiGene, Ltd. | 367 |
9 |
| Genentech, Inc. | 3971 |
7 |
| SHY Therapeutics LLC | 29 |
7 |
| Amgen Inc. | 4072 |
6 |
| Medivir AB | 131 |
6 |
| Impetis Biosciences Ltd. | 29 |
6 |
| Merck Sharp & Dohme LLC | 3750 |
5 |
| F. Hoffmann-La Roche AG | 7930 |
4 |
| Merck Sharp & Dohme Corp. | 2197 |
4 |
| Takeda Pharmaceutical Company Limited | 2714 |
3 |
| ATIR Holding S.A. | 18 |
3 |
| Auburn University | 501 |
3 |
| Tango Therapeutics, Inc. | 45 |
3 |
| Novartis AG | 10847 |
2 |
| The Regents of the University of California | 19898 |
2 |
| AstraZeneca AB | 2920 |
2 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10923 |
2 |
| Consejo Superior de Investigaciones Cientificas (csic) | 1367 |
2 |
| Eli Lilly and Company | 3841 |
2 |
| Gilead Sciences, Inc. | 2037 |
2 |
| Other owners | 87 |